Notice Concerning Issuance of New Shares by way of Third-Party Allotment (A-2 Series)

2020.01.31

On January 31, 2020, the Company conducted a capital increase (Series A-2) by issuing new shares through a third-party allotment to three venture capital firms.

Latest posts

2023.07.13 News
Participate and speak at the “KLSAP2023 Pitch Event” (Jul. 14).
2023.06.22 News
Notice of website maintenance
2023.06.01 IR
Head office moved to Kyoto City Growth Industry Creation Center (ACT Kyoto).
2022.11.01 Press Release
We will start joint research with Mochida Pharmaceutical Co. ,Ltd
2022.10.30 Press Release
We reported the financial results at the regular general meeting of shareholders.
2021.11.01 IR
Notice Concerning Issuance of Stock Acquisition Rights through Crowdfunding
2021.09.01 R&D
Research and development of exosomes will be resumed.
2021.03.16 News
“ACHIEVEMENTS” Page has been updated.
2020.10.30 News
Participated in “Japan Healthcare Venture Summit 2020” (Oct. 14-16).
2020.06.23 News
Received a certificate of commendation and a commemorative gift from Senshu Ikeda Bank (Award for Excellence in the “16th Innovation Research and Development Grant”)

Latest posts

Participate and speak at the “KLSAP2023 Pitch Event” (Jul. 14).

Notice of website maintenance

Head office moved to Kyoto City Growth Industry Creation Center (ACT Kyoto).

We will start joint research with Mochida Pharmaceutical Co. ,Ltd

We reported the financial results at the regular general meeting of shareholders.

Notice Concerning Issuance of Stock Acquisition Rights through Crowdfunding

Research and development of exosomes will be resumed.

“ACHIEVEMENTS” Page has been updated.

Participated in “Japan Healthcare Venture Summit 2020” (Oct. 14-16).

Received a certificate of commendation and a commemorative gift from Senshu Ikeda Bank (Award for Excellence in the “16th Innovation Research and Development Grant”)